Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Alignment Healthcare's enterprise value is $2,649 Mil.
Alignment Healthcare's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was $87 Mil. Therefore, Alignment Healthcare's EV-to-EBITDA for today is 30.61.
The historical rank and industry rank for Alignment Healthcare's EV-to-EBITDA or its related term are showing as below:
ALHC'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -101.42 Med: -11.4 Max: 2277.84
Current: 30.61
During the past 7 years, the highest EV-to-EBITDA of Alignment Healthcare was 2277.84. The lowest was -101.42. And the median was -11.40.
ALHC's EV-to-EBITDA is ranked worse than 86.67% of 15
companies
in the Healthcare Plans industry
Industry Median: 14.15
vs ALHC: 30.61
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Alignment Healthcare's PE Ratio (TTM) for today is calculated as:
Alignment Healthcare's share price for today is $14.555.
Alignment Healthcare's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.190.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Alignment Healthcare's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Healthcare Plans subindustry, Alignment Healthcare's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alignment Healthcare EV-to-EBITDA vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Alignment Healthcare's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Alignment Healthcare's EV-to-EBITDA falls into.
Alignment Healthcare's current Enterprise Value is $2,649 Mil.
Alignment Healthcare's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $87 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alignment Healthcare (ALHC) has a EV-to-EBITDA of 30.61 as of Aug. 04, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Alignment Healthcare. According to the industry distribution chart, Alignment Healthcare ranks #13 out of 15 companies in the Healthcare Plans industry, placing it in the top 86.7%.
Is Alignment Healthcare's EV-to-EBITDA too high?
Alignment Healthcare's current EV-to-EBITDA is 30.61. The Healthcare Plans industry median EV-to-EBITDA is 14.15. Alignment Healthcare's value of 30.61 is 116.3% above this industry median. Based on the distribution chart, Alignment Healthcare ranks #13 out of 15 companies in the Healthcare Plans industry, which is in the bottom quartile relative to peers. Overall, Alignment Healthcare has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alignment Healthcare's EV-to-EBITDA compare to PGNY and CLOV?
According to the Healthcare Plans industry distribution chart, Alignment Healthcare ranks #13 out of 15 companies for EV-to-EBITDA. This places Alignment Healthcare in the lower half of its industry. The industry median EV-to-EBITDA is 14.15. Alignment Healthcare's value of 30.61 is 116.3% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Plans company?
The median EV-to-EBITDA among Healthcare Plans companies is 14.15, based on 15 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Alignment Healthcare's current EV-to-EBITDA of 30.61 is 116.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Alignment Healthcare. For the Healthcare Plans industry, the median EV-to-EBITDA is 14.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Alignment Healthcare's current EV-to-EBITDA is 30.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alignment Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Alignment Healthcare (ALHC) is currently considered Modestly Undervalued. The stock's GF Value™ is $20.22, compared to a current price of $14.56 — trading 28% below its estimated fair value. The current EV-to-EBITDA is 30.61 and 116.3% above the Healthcare Plans industry median of 14.15. Alignment Healthcare's overall GF Score™ is 79/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Alignment Healthcare (ALHC), the current EV-to-EBITDA is 30.61 as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alignment Healthcare (ALHC) Overvalued in 2026?
Based on GuruFocus' analysis, Alignment Healthcare stock appears to be undervalued.
The current stock price of $14.56 is trading 28% below its estimated GF Value™ of $20.22.
GuruFocus considers Alignment Healthcare to be Modestly Undervalued.
Key valuation signals for ALHC:
EV-to-EBITDA: 30.61
GF Value™: $20.22 vs. price of $14.56 (28% below fair value)
Industry Position: 116.3% above the Healthcare Plans median (#13 of 15)
No single metric tells the full story. See the ALHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.
79GF Score
Get the complete analysis for ALHC
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ALHC has been successfully added to your 
